Stock Events

Stock Events

BridgeBio Oncology Therapeutics (BBOT) Q2 2026 Earnings

BBOT
May 12Confirmed
Q3 2025
Q4 2025
Q2 2026
-49.62
-33.2
-16.79
-0.38

Details

Expected EPS
-0.51197
Actual EPS
-0.52611
Surprise EPS
-0.01
Surprise Percent
-2.76%

Description

⁨BridgeBio Oncology Therapeutics⁩ (⁦BBOT⁩) has reported earnings of ⁦-0.52611⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts